IGF1R genomic knock-out was detected using conventional PCR on cell lysates. Cells were trypsinized with 30 μL in the 96-well plate and stopped with 90 μL of complete medium. Two-thirds of the suspension (80 μL) was passaged for further growth, while the rest (40 μL) was transferred to a PCR tube for lysing. The PCR tubes were centrifuged for 3 min at 1500 rpm, the supernatant was aspirated and pellet re-suspended in 30 μL lysisbuffer (50 mM KCl, 1.5 mM MgCl 2 , 10 mM Tris/HCL, pH 8.5, 0.5 % Tween 20, 0.5 % Nonidet, 400 μg/mL Proteinase K). The cells were lysed at 65 °C for 30 min followed by 95 °C for 10 min in a thermal cycler. Lysates were stored at −20 °C. Amplification of the target region was performed with HCC827(IGF1R-/-)-PCR-screening primers (Eurofins genomics, Supplementary Table 1) . The primers were situated minimum 65 bp from nearest cleavage site giving rise to a IGF1R-wildtype amplicon of 300 bp and a HCC827(IGF1R-/-) amplicon of 199 bp. PCR screening was performed in a reaction mixture containing 0.03 units/μL HotStarTaq (Qiagen), 0.2 mM dNTP, 0.4 mM forward primer, 0.4 mM reverse primer, 1X Taq PCR buffer (Qiagen), 2.5 μL cell lysate and H 2 O to a volume of 25 μL. The reaction was conducted on a thermal cycler using the protocol: 15 min of heating at 95 °C followed by 40 cycles of denaturation at 95 °C for 15 sec., annealing at assay-specific T A °C for 15 sec and elongation at 72 °C for 30 sec., and finally one hold at 72 °C for 7 min followed by cooling to 4 °C. The PCR products were evaluated on an agarose gel, and PCR products were purified from the gel using NucleoSpin Gel and PCR clean-up kit (Machery-Nagel) following manufacturer's protocol. Sanger sequencing of the PCR products were performed by GATC Biotech.
Off-target analysis
In silico prediction of potential off-target sites for each sgRNA was performed using http://crispr.mit.edu/. The 4 most likely off-target sites for each sgRNA with a quality score above 0.5 were chosen for investigation. PCR assays were designed for each site with primers (Eurofins Genomics, Supplementary Table 1) covering the potential cleavage site and investigated in both parental cell lines (HCC827 and HCC827(IGF1R-/-)). DNA was obtained from cells by DNA purification using a NaCl precipitation protocol. Briefly, one fourth of a T75 culture flask was scraped and cells were spun for 5 min at 1800 rpm. Cell pellet was washed in PBS and spun again at 1600 rpm for 5 min. The cell pellet was lysed in 500 μL Chorion Villus Lysisbuffer (10 mM Tris, 1 mM EDTA, 150 mM NaCl, 0.5 % SDS, pH 10.5) with 5 μL 20 mg/ mL Proteinase K for 2.5 h at 55°C. Samples were mixed with 165 μL 6M NaCl and centrifuged for 15 min at 13000 rpm. Propan-2-ol was added to supernatant in 1:1 volume, and tubes were turned upside down until DNA treads became visible. DNA was captured with glass needles and re-suspended in 100 μL TE buffer. DNA concentration was measured the next day. Conventional PCR amplification was performed using 75 ng purified DNA. A proportion of the PCR products were evaluated on agarose gel and the remaining were purified from the PCR mixture using NucleoSpin Gel and PCR Clean-up kit (Machery-Nagel). Sanger sequencing of the PCR products was performed by GATC Biotech.
Receptor tyrosine kinase arrays
The Proteome Profiler™ Human Phospho-RTK Array kit (R&D Systems) was used for screening of relative phosphorylation status of 49 key receptor tyrosine kinases following the manufacturer's instructions. The nitrocellulose membranes were blocked for 1 h at room temperature followed by incubation with 300 μg cell lysate at 4 °C overnight with rotation. The next day the membranes were incubated with Anti-Phospho-Tyrosine-HRP Detection Antibody (1:5000) for 2 h at room temperature with rotation. All membranes were developed concurrently using an ImageQuant LAS 4000 system (GE Healthcare Life Sciences) and IQLAS4000 Control Software. 
Supplementary Figure 4:
Progressive gene expression changes during resistance development. mRNA expression level was assessed by qPCR analysis in samples obtained progressively throughout resistance development for HCC827 (beige) and HCC827(IGF1R−/−) (red). Gene expression was normalized to IPO8 and expression levels for each passage are presented relatively to "HCC827 (beige) passage 0". Expression levels are based on one biological sample and illustrated as mean ± SD. 
